Guardant Health Inc.

The momentum for this stock is not very good. Guardant Health Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Guardant Health Inc..
Log in to see more information.
Guardant Health, Inc. is a precision oncology company, which engages in provision of precision oncol...
GH Fundamental Data by TradingView

News

Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?
Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?

Zacks Investment Research Liquidia Technologies, Inc. (LQDA) shares rallied 14.1% in the last trading session to close at $10.16. This move can be attributable to notable volume with a higher number of shares being traded...\n more…

Guardant Health management to meet with Craig-Hallum
Guardant Health management to meet with Craig-Hallum

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

GH Makes Bullish Cross Above Critical Moving Average
GH Makes Bullish Cross Above Critical Moving Average

Market News Video In trading on Tuesday, shares of Guardant Health Inc (GH) crossed above their 200 day moving average of 24.67, changing hands as high as 25.87 per share. Guardant Health Inc shares are...\n more…

Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy

Business Wire Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a partnership with the Agostino Gemelli University Polyclinic Foundation IRCCS (Policlinico Gemelli) to...\n more…

Guardant Health, Inc. (NASDAQ:GH) Receives $39.31 Average PT from Brokerages
Guardant Health, Inc. (NASDAQ:GH) Receives $39.31 Average PT from Brokerages

Ticker Report Shares of Guardant Health, Inc. (NASDAQ:GH - Get Free Report) have been given an average rating of "Moderate Buy" by the seventeen research firms that are currently covering the stock, MarketBeat.com...\n more…

Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Candriam S.C.A.
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Candriam S.C.A.

Ticker Report Candriam S.C.A. cut its stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 21.5% during the second quarter, HoldingsChannel reports. The institutional investor owned 366,145 shares of the...\n more…